Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets
- Andrew S. Weyrich*,†,‡,§,
- Dan A. Dixon‡,¶,
- Ravinder Pabla*,
- Mark R. Elstad*,†,‖,
- Thomas M. McIntyre*,†,**,
- Stephen M. Prescott†,¶,‡‡, and
- Guy A. Zimmerman*,†
- *Nora Eccles Harrison Cardiovascular Research and Training Institute, ¶Program in Human Molecular Biology and Genetics and Huntsman Cancer Institute, ‖Department of Medicine, Veterans Affairs Medical Center, and Departments of ‡‡Biochemistry, †Internal Medicine, and **Pathology, University of Utah, Salt Lake City, UT 84112
-
Communicated by Raymond L. White, University of Utah, Salt Lake City, UT (received for review January 8, 1998)
Abstract
Circulating human platelets lack nuclei, cannot synthesize mRNA, and are considered incapable of regulated protein synthesis. We found that thrombin-activated, but not resting, platelets synthesize Bcl-3, a member of the IκB-α family of regulatory proteins. The time- and concentration-dependent generation of Bcl-3 in platelets signaled by thrombin was blocked by translational inhibitors, by rapamycin, and by inhibitors of phosphatidylinositol-3-kinase, indicating that it occurs via a specialized translational control pathway that involves phosphorylation of the inhibitory protein 4E-BP1. After its synthesis in activated platelets Bcl-3 binds to the SH3 domain of Fyn (p59fyn), a Src-related tyrosine kinase. This, along with its expression in anucleate cells, suggests that Bcl-3 has previously unrecognized functions aside from modulation of transcription. We also demonstrate that platelets synthesize and secrete numerous proteins besides Bcl-3 after they adhere to fibrinogen, which mediates adhesion and outside–in signaling of these cells by engagement of αIIb/β3 integrin. Taken together, these data demonstrate that regulated synthesis of proteins is a signal-dependent activation response of human platelets.
Footnotes
-
↵ ‡ A.S.W. and D.A.D. contributed equally to this work.
-
↵ § To whom reprint requests should be addressed at: Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT 84112. e-mail: andrew_weyrich{at}gatormail.cvrti.utah.edu.
- ABBREVIATIONS:
- Bcl-3,
- B cell lymphoma-3;
- eIF4E,
- eukaryotic initiation factor 4E;
- SH2 and SH3,
- src homology 2 and 3, respectively;
- 4E-BP1,
- eIF4E-binding protein 1;
- PI 3-kinase,
- phosphatidylinositol 3-kinase
- Copyright © 1998, The National Academy of Sciences





